- 300 mg Beta Sitosterol, as PURE plant Sterols
- 10 mg Roche Pharmaceutical Grade Lycopene
- 100 mg Linumlife Concentrated Lignans
- Promotes Maximum Prostate Health
Formulated to Promote Prostate Health Free From Cancer
Read these published clinical studies. We are certain you will agree Lyco-Prostate
is essential for your own prostate health and recovery from prostate cancer.
Serving Size :
| Ingredient |
Quantity |
Measure |
RDA * |
Lyco-Prostate w/ LinumLife
|
|
|
|
Serving Size: One capsule; Ingredients per capsule
|
|
|
|
Beta-Sitosterols
|
300 |
mg |
Not Established |
Lycopene (as 5% beadlets)
|
10 |
mg |
N/E |
LinumLife complex (as lignans 3.5% extract from flax seed
powder)
|
100 |
mg |
N/E |
Lycopene Linked to Lower Prostate Cancer Risk
A high level of lycopene in the blood serum correlates to a lower risk of
prostate cancer, according to new research published in the latest edition of
the American Journal of Epidemiology.
Researchers from the US National Cancer Institute in Bethesda, Maryland, led
by Dr Tara M. Vogt, focused on 437 men, some 209 of whom had prostate cancer.
Vogt's team wanted to find conclusive evidence that the level of carotenoids
such as lycopene found in the body were related to the incidence of prostate
cancer, since earlier studies had given mixed results.
Carotenoids are found in a variety of vegetables such as tomatoes, carrots,
watermelon and spinach, and include lutein and zeaxanthin as well as lycopene.
They have been linked to a number of potential health benefits such as cancer
prevention and lung health.
The team discovered that men with the highest levels of serum lycopene had
a 35 per cent lower risk of developing prostate cancer than those with the lowest
levels. While they also found that intake of other carotenoids was linked to
an increase in prostate cancer levels, none of the findings were statistically
significant.
Vogt's team also wanted to discover why prostate cancer rates were higher in
black men than in white, and both the control and the study group contained
comparable numbers of men from both backgrounds.
They discovered that the correlation between carotenoid levels and prostate
cancer risk were similar in both black and white men but that serum lycopene
levels were significantly lower in blacks than in whites. This, they claimed,
could explain why prostate cancer levels are higher in blacks than in whites.
"Our findings provide support for the protective role of lycopene in prostate
carcinogenesis," Vogt said. "Hypotheses that other individual carotenoids
are associated with a reduced risk of prostate cancer were not supported."
Take one Capsule Twice a day
